SRDX News and Press, Surmodics Inc. From 08/05/20

Device designed to treat below-the-knee vessels from the radial arteries with industry’s longest (250 cm) working length Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced it has recei...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2020 third quarter ended June 30, 2020. Summary of Third Quarter and Recent Highlights Revenue of $26.9 mill...

Webcast is Live at 4 p.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2020 conference call on Wednesday, August ...

Surmodics ( SRDX +3.5% ) announces CE Mark certification of its SurVeil drug-coated balloon used to treat peripheral artery disease (PAD). More news on: Surmodics, Inc., Abbott Laboratories, Healthcare stocks news, Stocks on the move, Read more ...

Next generation device adds new technology to how physicians approach treatment of PAD Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced it has received CE Mark Certification in the Euro...

Image source: The Motley Fool. SurModics   (NASDAQ: SRDX) Q2 2020 Earnings Call Apr 29, 2020 , 5:00 p.m. ET Operator Continue reading

Surmodics, Inc. (SRDX) Q2 2020 Earnings Conference Call April 29, 2020 5:00 PM ET Company Participants Tim Arens – Vice President-Finance and Chief Financial Officer Gary Maharaj – Chief Executive Officer Conference Call Participants Brooks O’Neil –...

Surmodics (NASDAQ: SRDX ): Q2 Non-GAAP EPS of $0.04 beats by $0.15 ; GAAP EPS of $0.11 beats by $0.28 . More news on: Surmodics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2020 second quarter ended March 31, 2020, and suspended its financial guidance for fiscal 2020. Summary of Second Q...

Webcast is Live at 4 p.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2020 conference call on Wednesday, April ...